A system has been developed that allows efficient production of monkey monoclonal antibodies from owl monkeys. Splenocytes or peripheral blood lymphocytes from monkeys immune to the human malarial parasite, Plasmodium fakiparum, were fused with P3X63 Ag8.653 mouse myelomas. The resulting hybridomas were screened by an indirect fluorescent antibody test for the production of monkey monoclonal antibodies (mAb) reactive with P. falciparum. Most of the mAb reacted with the P. falciparum merozoites and immunoprecipitated a parasite-derived glycoprotein having a relative molecular weight of 185,000. These mAb gave a minimum of five different immunoprecipitation patterns, thus demonstrating that a large number of polypeptides obtained when parasitized erythrocytes are solubilized share epitopes with this large glycoprotein. In addition, mAb were obtained that reacted with antigens associated with the infected erythrocyte membrane. One of these mAb bound a Mr 95,000 antigen. Particular subspecies of owl monkeys (genus Aotus) provide the best model for human malaria. Blood stages of the human malarial parasite Plasmodium falciparum produce a lifethreatening disease in naive animals that, when cured with drugs, leaves the animals highly immune. Future challenge with very large doses of parasitized erythrocytes produces barely detectable parasitemias (1) . Humans respond to the parasite in a similar fashion but may not develop as strong an immunity. However, because of the genetic similarity between primates and humans, it is probable that the immunologic solution devised by the monkey will also be applicable in man. Langreth and Reese (2) have shown that sera from immune owl monkeys contain antibodies that bind to the surface of merozoites and parasitized erythrocytes. These antibodies can inhibit in vitro growth of the parasite (1, 3) and provide immunity to other animals when transferred passively (unpublished data).
Particular subspecies of owl monkeys (genus Aotus) provide the best model for human malaria. Blood stages of the human malarial parasite Plasmodium falciparum produce a lifethreatening disease in naive animals that, when cured with drugs, leaves the animals highly immune. Future challenge with very large doses of parasitized erythrocytes produces barely detectable parasitemias (1) . Humans respond to the parasite in a similar fashion but may not develop as strong an immunity. However, because of the genetic similarity between primates and humans, it is probable that the immunologic solution devised by the monkey will also be applicable in man. Langreth and Reese (2) have shown that sera from immune owl monkeys contain antibodies that bind to the surface of merozoites and parasitized erythrocytes. These antibodies can inhibit in vitro growth of the parasite (1, 3) and provide immunity to other animals when transferred passively (unpublished data).
Here we present a method for producing monoclonal antibodies (mAb) from Aotus monkeys. Antibodies that detect a series of different epitopes associated with the surface of merozoites as well as those that bind to parasite antigens found in the membrane or cytoskeleton of the parasitized erythrocyte are given as examples. The fusion efficiency of this monkey-mouse system is at least as high as found with mouse-mouse fusions and the levels of antibody produced by stable hybrids appear to be similar to those from mouse-homo hybrids. This system is likely to have wide application in the study of other infectious agents because the epitopes seen by the primate should be more relevant to producing human immunity than structures seen by a rodent that cannot experience the disease. Similarly, this system may also be useful in elucidating the antigenic composition of plasma membranes from other cells (transformed or nontransformed) that can survive in the monkey and induce a strong immune response.
MATERIALS AND METHODS Cells. The Plasmodiumfalciparum FVO isolate was grown in human O+ erythrocytes using the candle jar method of Trager and Jensen (4) . To obtain material enriched for segmenters and merozoites, the cultures were treated with Physiogel (5) when most of the parasites were early trophozoi' s. Infected erythrocytes (50-70% parasitemia) were returned to culture (0.5% hematocrit) for 18 hr. Segmenters and free merozoites were harvested, washed twice with RPMI 1640 medium, and used as follows: (i) repeatedly frozen and thawed for lymphocyte stimulation, (ii) stored at -70°C as antigen for immunoblot analyses, (iii) smeared on slides and acetone fixed for indirect fluorescence antibody tests (IFAT), and (iv) used unfixed for IFAT on cells in suspension. To obtain metabolically labeled parasites [35S]methionine or [3H]glucosamine (1 mCi/10 ml; 1 Ci = 37 GBq) was included in the culture medium during the 18-hr incubation of the Physiogel-concentrated parasites.
The P3X63 Ag8.653 myeloma (6) was adapted to and subsequently grown in Dulbecco's high-glucose medium (Irvine Scientific) supplemented with 10% gamma-globulinfree horse serum (GIBCO). The cells were subcultured daily to 4 x 195 cells per ml for at least 3 days prior to any cell fusion experiments.
Fusions. The Aotus monkey (karyotype II) used as a source of splenocytes had previously been infected three times with the P. falciparum FVO isolate and was judged to be immune to this isolate because the injection of a normally lethal dose of this parasite resulted in little or no detectable parasitemia. One year after the last infection, the monkey was injected intraperitoneally with 0.2 ml of frozen and thawed segmenters and free merozoites. Three days later, the monkey was splenectomized and carefully monitored to ensure complete recovery. The spleen was gently teased apart and the splenocytes were washed with cold phosphate-buffered saline and frozen in 10%o dimethyl sulfoxide, 50% RPMI 1640 and 40% fetal bovine serum.
At the time of a fusion one vial of 5-10 X 106 cells was rapidly thawed at 37°C, washed twice with Dulbecco's high-glucose medium, and mixed with an equal number of similarly washed P3X63 Ag8.653 myelomas. The cells were then pelleted by centrifugation for 10 min at 1300 x g. After removing the supernatant, the pellet was gently loosened. One milliliter of 37°C fusion promoter (35% PEG 1000 and 7.5% dimethyl sulfoxide in RPMI 1640) was slowly added over a 1-min time interval. Warm Dulbecco's medium containing 10% gamma-globulin-free horse serum was then slowly added, 2 ml in a 2-min interval followed by 8 ml in 2 min. After centrifugation for 10 min at 1300 x g, the fused Abbreviations: IFAT, indirect fluorescent antibody test; mAb, monoclonal antibody(ies); PBL, peripheral blood lymphocytes.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. cells were diluted to the appropriate cell density in Dulbecco's high-glucose medium containing 10% gammaglobulin-free horse serum, hypoxanthine (14 ,g/ml), aminopterin (0.45 ,g/ml), and thymidine (7.2 ,g/ml) (HAT medium) and dispensed in 96-well plates. BALB/c ByJ mouse thymocytes (2 x 106/ml) were used as a feeder layer. The cultures were fed weekly with HAT medium supplemented on days 7 and 15 with fresh thymocytes. Screening of the spent culture supernatants by IFAT using a fluorescein isothiocyanate conjugate of affinity-purified rabbit antiAotus IgG antibodies was initiated on day 21 and continued for 3 weeks.
A second immune monkey (karyotype VI), used as a source of peripheral blood lymphocytes (PBLs), had previously been infected with the FVO isolate five times within 2 years. A year after the last infection 7 ml of blood was drawn by vena puncture using heparin as an anticoagulant. The mononuclear cells were concentrated using Ficoll/Hypaque (Pharmacia) and washed twice with cold P1/NaCl. Then, 2 x 107 cells were stimulated in vitro for 4 days in 10 ml of Dulbecco's high-glucose medium supplemented with 10% fetal bovine serum, 50 ,tM 2-mercaptoethanol, and 40 ,l frozen and thawed segmenters and free merozoites. The surviving PBLs (1 x 107) were washed, fused with an equal number of P3X63 Ag8.653 cells, and cultured as described above.
Hybridomas were also prepared using splenocytes from an immunized mouse. In this experiment a BALB/c ByJ mouse was injected three times (days 1, 60, 150) with frozen and thawed parasite material corresponding to _107 infected erythrocytes. Three days after the final injection, the spleen was removed and the splenocytes were fused with the mouse myelomas as described above. The hybridoma culture supernatants were screened by IFAT using a fluorescein isothiocyanate conjugate of affinity-purified goat anti-mouse IgG and IgM antibodies (Tago, Burlingame, CA).
Immunological Assays. Immunoprecipitation assays were done to characterize the molecules with which the monkey mAbs reacted. Metabolically labeled parasites (see above) were lysed in a detergent containing radioimmunoprecipitation assay buffer (RIPA buffer A, ref. 7) and insoluble material was removed by centrifugation for 1 hr at 150,000 x g. The lysate was then used to resuspend protein ASepharose to which mAbs had been bound previously. Protein A-Sepharose lacking antibody was used as a negative control. After 1 hr in the lysate the beads were washed three times with RIPA buffer, once with RIPA buffer containing 0.5 M NaCl, and once with distilled H20. The beads were boiled in sample buffer (8) and the eluted antigens were electrophoresed on 8% NaDodSO4/polyacrylamide gels in parallel with "'C-labeled molecular weight markers (carbonic anhydrase, 30,000; ovalbumin, 43,000; IgG heavy chain, 53,000; and myosin, 200,000).
A previously described (9) immunoblotting procedure was used to test supernatants from some of the hybridomas. The proteins were first resolved by 6% NaDodSO4/PAGE and then blotted onto nitrocellulose sheets. After treating the sheets with the hybridoma supernatants, bound antibodies were detected using '251-labeled affinity-purified rabbit antiAotus IgG antibodies followed by fluorography. In preliminary experiments, "4C-labeled molecular weight markers (see above) were also run into the gels and blotted. These were used to standardize the reactivity of one mAb in the immunoblots. The antigens recognized by this mAb were subsequently used as molecular weight markers in other immunoblots. nized by mAb 9-6D. The major peptides found in each lane appear to share epitopes rather than being coprecipitated as a complex. This is demonstrated in Fig. 2 (lane 2) since all of the major bands are detectable when the parasite antigens are first separated by NaDodSO4 gel electrophoresis and then subjected to immunoblot analysis with mAb 9-6D. From a more recent fusion we have obtained several monkey mAbs (e.g., 6-1OG) that bind to antigens associated with the plasma membrane of the infected erythrocyte (Fig.  3) . mAb 6-1OG did not bind to acetone-fixed uninfected erythrocytes, to infected erythrocytes containing live parasites, or to acetone-fixed erythrocytes containing a variant of the FVO isolate that no longer modifies the host membrane by the formation of knobs. The mAb (lane 1 of Fig. 2 ) reacted strongly with a polypeptide of Mr 95,000 and weakly with a polypeptide of Mr 90,000 when used in immunoblot analyses. Immunization by infection provides the animal with the organism and its components in an authentic replicating form in contrast to the possibly altered forms found in a culture. In the case of P. falciparum, ample evidence suggests that dramatic changes can occur within a relatively short time in culture (3, 11) . Immunization with such material is likely to provide limited stimulation against some antigens that may be important in immunity. Evidence that the monkey system has helped this situation comes from the observation that from one fusion using 107 monkey splenocytes, we 
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